Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
71.10
+0.16 (0.23%)
Jul 30, 2026, 10:51 AM EDT - Market open
Utah Medical Products Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 87.53 | 85.76 | 82.98 | 92.87 | 75.05 | 60.97 |
Cash & Short-Term Investments | 87.53 | 85.76 | 82.98 | 92.87 | 75.05 | 60.97 |
Cash Growth | 6.51% | 3.35% | -10.65% | 23.74% | 23.09% | 18.19% |
Accounts Receivable | 3.57 | 3.52 | 4.09 | 3.39 | 5.54 | 5.13 |
Inventory | 9 | 7.94 | 8.81 | 9.58 | 8.81 | 6.6 |
Other Current Assets | 0.54 | 0.53 | 0.45 | 0.43 | 0.52 | 0.46 |
Total Current Assets | 100.64 | 97.74 | 96.33 | 106.27 | 89.92 | 73.16 |
Net Property, Plant & Equipment | 9.63 | 9.91 | 9.76 | 10.55 | 10.22 | 10.62 |
Other Intangible Assets | - | 0.84 | 2.87 | 4.95 | 10.38 | 17.76 |
Goodwill | - | 14.05 | 13.58 | 13.69 | 13.35 | 14.1 |
Total Assets | 124.57 | 122.54 | 122.54 | 135.46 | 123.87 | 115.64 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.88 | 0.91 | 0.7 | 0.77 | 1.22 | 0.76 |
Accrued Expenses | 1.19 | 1.69 | 3.06 | 3.94 | 4.74 | 2.98 |
Total Current Liabilities | 2.07 | 2.6 | 3.76 | 4.71 | 5.96 | 3.75 |
Long-Term Leases | 0.19 | 0.23 | 0.28 | 0.3 | 0.34 | 0.4 |
Other Long-Term Liabilities | 0.27 | 0.45 | 1.07 | 2.14 | 3.32 | 4.36 |
Total Long-Term Liabilities | 0.47 | 0.68 | 1.35 | 2.44 | 3.66 | 4.75 |
Total Liabilities | 2.54 | 3.27 | 5.11 | 7.15 | 9.62 | 8.5 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
Additional Paid-in Capital | - | - | - | 0.59 | 0.25 | 0.84 |
Accumulated Other Comprehensive Income | - | -9.42 | -11.91 | -10.66 | -12.04 | -9.05 |
Retained Earnings | - | 128.65 | 129.3 | 138.34 | 126.01 | 115.31 |
Shareholders' Equity | - | 119.27 | 117.43 | 128.31 | 114.25 | 107.14 |
Total Liabilities & Equity | 124.57 | 122.54 | 122.54 | 135.46 | 123.87 | 115.64 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.19 | 0.23 | 0.28 | 0.3 | 0.34 | 0.4 |
Net Cash (Debt) | 87.33 | 85.53 | 82.69 | 92.57 | 74.71 | 60.58 |
Net Cash Growth | 6.60% | 3.43% | -10.67% | 23.91% | 23.33% | 18.19% |
Net Cash Per Share | 27.35 | 26.40 | 23.61 | 25.45 | 20.51 | 16.55 |
Book Value | - | 119.27 | 117.43 | 128.31 | 114.25 | 107.14 |
Book Value Per Share | - | 36.81 | 33.52 | 35.28 | 31.36 | 29.27 |
Tangible Book Value | - | 104.38 | 100.98 | 109.68 | 90.52 | 75.28 |
Tangible Book Value Per Share | - | 32.21 | 28.83 | 30.16 | 24.85 | 20.57 |